archiveQure.ai

Evidence presented at 2024 World Conference on Lung Cancer highlights chest X-ray AI’s potential to detect lung nodules early and...

This achievement marks Qure.ai's first large language model (LLM) patent, cementing its status as a leader in innovation Qure.ai, a...

Qure.ai, a global leader in healthcare AI, has been honoured with a Startup Award by Siemens Healthineers. This accolade recognizes...

Qure.ai, a global leader in healthcare AI, has recently demonstrated the significant potential impact of Artificial Intelligence (AI) on stroke...

Congratulations on Qure.ai's recent achievement of receiving breakthrough device designation from the FDA for its qSpot-TB solution. Can you tell...

The qSpot-TB AI is a second-read computer aided detection & diagnosis device that analyses chest X-rays to localize all noted...

To augment tumor assessments using AI-enabled solutions for clinical trials & cancer care The collaboration aims to increase efficiency &...

This also marks the 6th FDA clearance for Qure’s chest X-ray based solutions Notably, this is the only FDA-cleared solution...

Qure solidifies its position as an innovation powerhouse with 26 patents secured in total Qure.ai, a global medical imaging AI...